Rohan Bir Singh, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Corneal Perforation | 6 | 2022 | 32 | 2.750 |
Why?
|
Dry Eye Syndromes | 8 | 2022 | 386 | 2.740 |
Why?
|
Keratitis, Herpetic | 3 | 2023 | 81 | 2.290 |
Why?
|
Keratitis | 5 | 2022 | 268 | 2.110 |
Why?
|
Corneal Ulcer | 4 | 2022 | 169 | 2.080 |
Why?
|
Keratoconus | 2 | 2024 | 121 | 1.660 |
Why?
|
Uveitis | 4 | 2023 | 375 | 1.580 |
Why?
|
Corneal Transplantation | 4 | 2023 | 386 | 1.560 |
Why?
|
Conjunctivitis | 2 | 2021 | 158 | 1.430 |
Why?
|
Hyperemia | 2 | 2021 | 225 | 1.430 |
Why?
|
Corneal Diseases | 4 | 2024 | 636 | 1.290 |
Why?
|
Glaucoma | 3 | 2023 | 1159 | 1.230 |
Why?
|
Corneal Dystrophies, Hereditary | 3 | 2022 | 81 | 1.160 |
Why?
|
Keratoplasty, Penetrating | 2 | 2023 | 155 | 1.040 |
Why?
|
Eye Injuries | 2 | 2018 | 245 | 1.030 |
Why?
|
Retinal Diseases | 3 | 2021 | 683 | 1.020 |
Why?
|
Cornea | 9 | 2024 | 1524 | 0.980 |
Why?
|
Cataract | 2 | 2022 | 834 | 0.970 |
Why?
|
Macular Degeneration | 2 | 2022 | 981 | 0.970 |
Why?
|
Uveitis, Posterior | 2 | 2023 | 44 | 0.950 |
Why?
|
Vaccines | 2 | 2023 | 822 | 0.940 |
Why?
|
Choroiditis | 1 | 2022 | 12 | 0.880 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2023 | 36 | 0.880 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2022 | 27 | 0.840 |
Why?
|
Serpins | 2 | 2021 | 247 | 0.840 |
Why?
|
Tissue Adhesives | 2 | 2020 | 179 | 0.820 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 1 | 2023 | 109 | 0.810 |
Why?
|
Lacrimal Apparatus | 2 | 2021 | 225 | 0.810 |
Why?
|
Nerve Growth Factors | 2 | 2021 | 576 | 0.760 |
Why?
|
Paraproteinemias | 1 | 2023 | 247 | 0.730 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2021 | 142 | 0.730 |
Why?
|
Eye Proteins | 2 | 2021 | 646 | 0.730 |
Why?
|
Herpes Simplex | 1 | 2023 | 470 | 0.690 |
Why?
|
Ichthyosiform Erythroderma, Congenital | 1 | 2018 | 7 | 0.680 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2019 | 48 | 0.670 |
Why?
|
Graft Rejection | 2 | 2023 | 4399 | 0.670 |
Why?
|
Amebiasis | 1 | 2018 | 34 | 0.660 |
Why?
|
Acanthamoeba Keratitis | 1 | 2018 | 17 | 0.660 |
Why?
|
Eye Infections, Bacterial | 1 | 2021 | 235 | 0.660 |
Why?
|
Optic Nerve Neoplasms | 1 | 2018 | 44 | 0.620 |
Why?
|
Graft vs Host Disease | 5 | 2022 | 2957 | 0.620 |
Why?
|
Lighting | 1 | 2020 | 231 | 0.600 |
Why?
|
Th17 Cells | 2 | 2021 | 766 | 0.600 |
Why?
|
Eye Diseases | 1 | 2023 | 668 | 0.590 |
Why?
|
Sclera | 1 | 2018 | 200 | 0.580 |
Why?
|
Glaucoma Drainage Implants | 1 | 2018 | 116 | 0.580 |
Why?
|
Eye Infections, Fungal | 1 | 2018 | 110 | 0.570 |
Why?
|
Glaucoma, Open-Angle | 1 | 2022 | 711 | 0.550 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1060 | 0.500 |
Why?
|
Eye | 4 | 2023 | 729 | 0.490 |
Why?
|
Corneal Edema | 2 | 2024 | 52 | 0.460 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1210 | 0.450 |
Why?
|
Choroid | 4 | 2023 | 322 | 0.440 |
Why?
|
Cardiovascular System | 1 | 2020 | 832 | 0.430 |
Why?
|
Radiation Injuries | 1 | 2020 | 1178 | 0.420 |
Why?
|
Trigeminal Nerve Diseases | 2 | 2022 | 55 | 0.380 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1789 | 0.380 |
Why?
|
Receptors, Neurokinin-1 | 2 | 2022 | 129 | 0.380 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2018 | 1380 | 0.370 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 2988 | 0.370 |
Why?
|
Health Care Costs | 1 | 2023 | 3209 | 0.360 |
Why?
|
Neoplasms, Second Primary | 1 | 2018 | 1061 | 0.360 |
Why?
|
Cyanoacrylates | 2 | 2020 | 49 | 0.350 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2023 | 469 | 0.350 |
Why?
|
Anesthesia | 1 | 2021 | 1548 | 0.350 |
Why?
|
Humans | 53 | 2024 | 744220 | 0.340 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.340 |
Why?
|
Pandemics | 3 | 2024 | 8387 | 0.330 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3132 | 0.310 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3239 | 0.310 |
Why?
|
Trabeculectomy | 2 | 2020 | 162 | 0.310 |
Why?
|
Conjunctiva | 2 | 2021 | 494 | 0.300 |
Why?
|
Vaccination | 3 | 2023 | 3278 | 0.280 |
Why?
|
Tomography, Optical Coherence | 4 | 2023 | 2657 | 0.280 |
Why?
|
Fluorescein Angiography | 4 | 2023 | 940 | 0.270 |
Why?
|
India | 3 | 2021 | 2199 | 0.270 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2022 | 5442 | 0.270 |
Why?
|
Prevalence | 6 | 2024 | 15226 | 0.250 |
Why?
|
Intraocular Pressure | 2 | 2022 | 1274 | 0.250 |
Why?
|
Cost of Illness | 2 | 2024 | 1859 | 0.240 |
Why?
|
Vision Disorders | 2 | 2021 | 1059 | 0.230 |
Why?
|
Eye Pain | 2 | 2022 | 47 | 0.230 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.230 |
Why?
|
alpha-MSH | 1 | 2023 | 68 | 0.230 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5138 | 0.220 |
Why?
|
Palliative Care | 1 | 2018 | 3490 | 0.220 |
Why?
|
Tears | 2 | 2022 | 256 | 0.220 |
Why?
|
Vision Tests | 1 | 2022 | 167 | 0.210 |
Why?
|
Retrospective Studies | 10 | 2023 | 77426 | 0.200 |
Why?
|
Middle Aged | 14 | 2023 | 213367 | 0.200 |
Why?
|
Schools | 2 | 2021 | 1433 | 0.200 |
Why?
|
Biology | 1 | 2024 | 294 | 0.200 |
Why?
|
Contrast Sensitivity | 1 | 2022 | 244 | 0.200 |
Why?
|
Epithelium, Corneal | 2 | 2022 | 247 | 0.200 |
Why?
|
Substance P | 1 | 2022 | 335 | 0.190 |
Why?
|
Antigen-Presenting Cells | 2 | 2023 | 973 | 0.190 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2022 | 125 | 0.190 |
Why?
|
Electrocoagulation | 1 | 2021 | 158 | 0.180 |
Why?
|
Immune Evasion | 1 | 2024 | 360 | 0.180 |
Why?
|
Female | 20 | 2023 | 380197 | 0.180 |
Why?
|
Timolol | 1 | 2020 | 52 | 0.180 |
Why?
|
Corneal Neovascularization | 1 | 2022 | 188 | 0.180 |
Why?
|
Male | 16 | 2023 | 350027 | 0.180 |
Why?
|
Ophthalmic Solutions | 1 | 2021 | 317 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 11732 | 0.180 |
Why?
|
Adult | 13 | 2023 | 214035 | 0.170 |
Why?
|
Photophobia | 1 | 2020 | 67 | 0.170 |
Why?
|
Asthenopia | 1 | 2019 | 12 | 0.170 |
Why?
|
Visual Field Tests | 1 | 2021 | 383 | 0.170 |
Why?
|
Intestinal Perforation | 1 | 2021 | 253 | 0.170 |
Why?
|
Acanthamoeba | 1 | 2018 | 13 | 0.170 |
Why?
|
Diabetic Ketoacidosis | 1 | 2022 | 247 | 0.170 |
Why?
|
Interleukin-1 | 1 | 2022 | 1263 | 0.160 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2024 | 3336 | 0.160 |
Why?
|
Diplopia | 1 | 2019 | 200 | 0.160 |
Why?
|
Blepharoptosis | 1 | 2019 | 144 | 0.160 |
Why?
|
Thrombospondin 1 | 1 | 2019 | 250 | 0.150 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2021 | 349 | 0.150 |
Why?
|
Dwarfism | 1 | 2018 | 145 | 0.150 |
Why?
|
Anterior Chamber | 1 | 2018 | 197 | 0.150 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18027 | 0.150 |
Why?
|
Computers, Handheld | 1 | 2019 | 208 | 0.150 |
Why?
|
Intravitreal Injections | 1 | 2018 | 345 | 0.140 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2023 | 1121 | 0.140 |
Why?
|
Lysosomes | 1 | 2021 | 893 | 0.140 |
Why?
|
Terminally Ill | 1 | 2018 | 238 | 0.130 |
Why?
|
Databases, Factual | 1 | 2020 | 7730 | 0.130 |
Why?
|
Educational Status | 1 | 2023 | 2539 | 0.130 |
Why?
|
Aged | 9 | 2023 | 163253 | 0.130 |
Why?
|
Reading | 1 | 2019 | 558 | 0.130 |
Why?
|
Animals | 12 | 2024 | 168788 | 0.130 |
Why?
|
Ophthalmology | 1 | 2021 | 508 | 0.120 |
Why?
|
Simplexvirus | 1 | 2018 | 802 | 0.120 |
Why?
|
Optic Nerve | 1 | 2018 | 556 | 0.120 |
Why?
|
Drug Combinations | 1 | 2020 | 1962 | 0.120 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15161 | 0.120 |
Why?
|
Visual Acuity | 2 | 2020 | 2530 | 0.120 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 21824 | 0.120 |
Why?
|
Health Resources | 1 | 2020 | 911 | 0.120 |
Why?
|
Streptozocin | 2 | 2024 | 193 | 0.110 |
Why?
|
Mice | 9 | 2024 | 81178 | 0.110 |
Why?
|
Graft Survival | 1 | 2023 | 3740 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2018 | 1849 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2047 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1040 | 0.110 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1741 | 0.100 |
Why?
|
United States | 3 | 2024 | 69867 | 0.100 |
Why?
|
Cytokines | 3 | 2021 | 7326 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1854 | 0.100 |
Why?
|
Neoplasms | 1 | 2020 | 21672 | 0.100 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57768 | 0.100 |
Why?
|
Treatment Outcome | 4 | 2023 | 63119 | 0.100 |
Why?
|
Internet | 1 | 2023 | 3063 | 0.090 |
Why?
|
Bacteria | 1 | 2021 | 2114 | 0.090 |
Why?
|
Public Health | 1 | 2024 | 2603 | 0.090 |
Why?
|
Gene Expression | 1 | 2022 | 7799 | 0.080 |
Why?
|
Retina | 1 | 2020 | 2616 | 0.080 |
Why?
|
Dendritic Cells | 1 | 2020 | 2725 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2136 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19907 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2020 | 3690 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4151 | 0.070 |
Why?
|
Young Adult | 4 | 2020 | 56436 | 0.070 |
Why?
|
Wound Healing | 3 | 2023 | 2785 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4297 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4252 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2018 | 2987 | 0.070 |
Why?
|
Child | 3 | 2023 | 77679 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4033 | 0.060 |
Why?
|
Adolescent | 4 | 2020 | 85759 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10634 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25043 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12961 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16365 | 0.060 |
Why?
|
Tissue Preservation | 1 | 2023 | 182 | 0.060 |
Why?
|
Cytoprotection | 1 | 2023 | 210 | 0.060 |
Why?
|
Fluorescein | 1 | 2022 | 171 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5319 | 0.050 |
Why?
|
Fundus Oculi | 1 | 2023 | 473 | 0.050 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2024 | 306 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 35423 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2023 | 15294 | 0.050 |
Why?
|
Fluorophotometry | 1 | 2021 | 40 | 0.050 |
Why?
|
Keratoconjunctivitis Sicca | 1 | 2021 | 27 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6773 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2023 | 390 | 0.050 |
Why?
|
Indocyanine Green | 1 | 2022 | 239 | 0.050 |
Why?
|
Colon, Sigmoid | 1 | 2021 | 120 | 0.050 |
Why?
|
Immunomodulation | 1 | 2024 | 541 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 644 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40063 | 0.040 |
Why?
|
Mutation | 1 | 2024 | 29784 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2024 | 759 | 0.040 |
Why?
|
Immune System | 1 | 2024 | 805 | 0.040 |
Why?
|
Photography | 1 | 2020 | 520 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11493 | 0.040 |
Why?
|
Quality of Life | 1 | 2018 | 12805 | 0.040 |
Why?
|
Pilot Projects | 2 | 2020 | 8321 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20123 | 0.030 |
Why?
|
Chronic Disease | 2 | 2021 | 9147 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 40992 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2023 | 6386 | 0.030 |
Why?
|
Monocytes | 1 | 2023 | 2594 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2022 | 2038 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3506 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3478 | 0.020 |
Why?
|
Risk Factors | 3 | 2024 | 72280 | 0.020 |
Why?
|
Cell Line | 1 | 2023 | 15999 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5657 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2213 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9275 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13409 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11478 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29142 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39045 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53280 | 0.010 |
Why?
|